Revenue + Forward P/E
Tenet Healthcare Corporation (THC) quarterly revenue and forward P/EForward P/E: 13.2x
RevenueRevenue (est)Forward P/E
Fair value & valuation models
Fair value models are a Plus feature
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
71% OFF$23.99 $6.99/mo
Ends in23:59:59
Cancel anytime. Secure checkout via Stripe.
Valuation
Market cap
$21.47B
Enterprise value
$27.17B
P/E ratio (TTM)
10.13x
P/S ratio (TTM)
0.79x
P/B ratio
3.54x
EV/Sales
1.27x
EV/EBITDA
5.57x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$21.31B
Gross profit (TTM)
$17.53B
Operating income (TTM)
$3.44B
EBITDA (TTM)
$4.48B
Net income (TTM)
$1.41B
Free cash flow (TTM)
$2.53B
Margins & returns
Gross margin
42.76%
Operating margin
16.14%
Profit margin
7.94%
Return on equity
40.55%
Return on assets
5.46%
Per-share metrics
EPS (TTM)
$19.62
Dividend yield
0.00%
Beta
1.27
Capital structure
Cash & equivalents
$2.88B
Total debt
$13.17B
Net debt
$10.29B
Shares outstanding
80.52M
Financial health
Current ratio
1.76
Debt / equity
3.12
Debt / assets
0.44
Interest coverage
4.19
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.11T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $628.43B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $441.19B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $364.64B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $348.28B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $332.34B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $21.47B | 10.13x | 0.79x | 5.57x | - |